BLISS GVS PHARMA
Back to All Ratios
|
BLISS GVS PHARMA Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROCE(%) | 12.29 | 12.15 | 12.22 | 6.37 | 12.49 |
What is the latest Return on Capital Employed (ROCE) ratio of BLISS GVS PHARMA ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2025 | 12.29 |
| Mar2024 | 12.15 |
| Mar2023 | 12.22 |
| Mar2022 | 6.37 |
| Mar2021 | 12.49 |
How is Return on Capital Employed (ROCE) of BLISS GVS PHARMA Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2025 | 12.29 | 1.15 | |
| Mar2024 | 12.15 | -0.57 | |
| Mar2023 | 12.22 | 91.84 | |
| Mar2022 | 6.37 | -49.00 | |
| Mar2021 | 12.49 | - | |
Other Financial Ratios of BLISS GVS PHARMA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹4,599.7 Cr | 14.1% | 57.4% | 208.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,469.0 Cr | -2.8% | -1% | 6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,305.0 Cr | -3.3% | 0.4% | -2.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,014.0 Cr | -3.1% | 2.9% | 36.9% | Stock Analytics | |
| CIPLA | ₹111,388.0 Cr | -2.7% | 5.3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,381.0 Cr | -4.1% | -3.7% | 3.7% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 14.1% |
57.4% |
208.4% |
| SENSEX | -2.4% |
-3.7% |
-9.2% |
You may also like the below Video Courses